WILMS TUMOR

Clinical trials for WILMS TUMOR explained in plain language.

Never miss a new study

Get alerted when new WILMS TUMOR trials appear

Sign up with your email to follow new studies for WILMS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 18 Not yet recruiting 1 Not yet finished but already full! 14 Completed 7

New hope for kids with resistant cancers: targeted drug enters trial

Disease control Not yet recruiting

This study tests a drug called ifinatamab deruxtecan (I-DXd) in children with solid tumors that have returned or not responded to treatment. The drug is an antibody-drug conjugate that targets cancer cells directly. The trial aims to check safety and see if tumors shrink in about…

Matched conditions: WILMS TUMOR

Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC

WILMS TUMOR

Get alerted when new WILMS TUMOR trials appear

New hope for kids with resistant cancers: targeted drug enters trial